Your browser doesn't support javascript.
loading
Widespread microglial activation in multiple system atrophy.
Kübler, Dorothee; Wächter, Tobias; Cabanel, Nicole; Su, Zhangjie; Turkheimer, Federico E; Dodel, Richard; Brooks, David J; Oertel, Wolfgang H; Gerhard, Alexander.
Afiliação
  • Kübler D; Movement Disorders Section, Department of Neurology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Berlin, Germany.
  • Wächter T; Hertie-Institute for Clinical Brain Research, Department of Neurodegenerative Diseases, Tübingen, Germany.
  • Cabanel N; Department of Neurology, Rehabilitation Centre Bad Gögging, Passauer Wolf, Bad Gögging, Germany.
  • Su Z; Vitos Clinical Centre for Psychiatry and Psychotherapy, Giessen-Marburg, Germany.
  • Turkheimer FE; Department of Neurosurgery, Salford Royal NHS Foundation Trust, Salford, UK.
  • Dodel R; Department of Neuroimaging, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
  • Brooks DJ; Chair of Geriatrics, University Hospital Essen, Center for Geriatric Medicine Haus Berge, Essen, Germany.
  • Oertel WH; Department of Nuclear Medicine and PET-Centre, Institute of Clinical Medicine, Aarhus University, Aarhus C, Denmark.
  • Gerhard A; Institute of Neuroscience, Newcastle University, Newcastle Upon Tyne, UK.
Mov Disord ; 34(4): 564-568, 2019 04.
Article em En | MEDLINE | ID: mdl-30726574
ABSTRACT

BACKGROUND:

The pattern and role of microglial activation in multiple system atrophy is largely unclear. The objective of this study was to use [11 C](R)-PK11195 PET to determine the extent and correlation of activated microglia with clinical parameters in MSA patients.

METHODS:

Fourteen patients with the parkinsonian phenotype of MSA (MSA-P) with a mean disease duration of 2.9 years (range 2-5 years) were examined with [11 C](R)-PK11195 PET and compared with 10 healthy controls.

RESULTS:

Patients with the parkinsonian phenotype of MSA showed a significant (P ≤ 0.01) mean increase in binding potentials compared with healthy controls in the caudate nucleus, putamen, pallidum, precentral gyrus, orbitofrontal cortex, presubgenual anterior cingulate cortex, and the superior parietal gyrus. No correlations between binding potentials and clinical parameters were found.

CONCLUSIONS:

In early clinical stages of the parkinsonian phenotype of MSA, there is widespread microglial activation as a marker of neuroinflammatory changes without correlation to clinical parameters in our patient population. © 2019 The Authors. Movement Disorders published by Wiley Periodicals, Inc. on behalf of International Parkinson and Movement Disorder Society.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Encéfalo / Microglia / Atrofia de Múltiplos Sistemas Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Encéfalo / Microglia / Atrofia de Múltiplos Sistemas Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article